WGS — GeneDx Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapHigh Flyer

Annual balance sheet for GeneDx Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	108	401	124	130	141
Net Total Accounts Receivable
Net Total Receivables	32.3	26.6	43.3	32.8	37.6
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	174	484	213	182	198
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	63.1	62.7	84.3	59.4	58.5
Net Intangible Assets
Other Long Term Assets
Total Assets	252	554	491	419	419
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	73.4	101	144	58.8	54.8
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	247	166	237	191	174
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	4.39	388	254	228	245
Total Liabilities & Shareholders' Equity	252	554	491	419	419
Total Common Shares Outstanding